Gout in the ED and Improving Research Participation
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, Boston, Cleveland, and Iowa City, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 200 people enrolled
- Started
- 1 Jun 2021
- Ended
- 1 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Storytelling
- Record updated
- 23 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Gout diagnosis meeting 2015 American College of Rheumatology and European League Against Rheumatism classification criteria,99,140
- Adult > 18 years of age
- Able to communicate and understand English language (a future objective, with additional resources, will include Spanish translation of all study materials)
Who cannot take part
- Joint complaint related to significant trauma or recent surgery (<1 month)
- Current critical illness leading to admission to high acuity medical care unit (ICU, stepdown unit) or requiring surgical intervention (general anesthesia); confirmed septic arthritis or joint infectious arthritis
- Life expectancy of < 6 months
Where in United States
- University of Alabama at BirminghamBirmingham, United States
- Massachusetts General HospitalBoston, United States
- MetroHealth Medical CenterCleveland, United States
- University of Iowa Hospitals and ClinicsIowa City, United States
About the trial
What the trial wants to find out
The prevalence of gout has been steadily increasing over several decades and is correlated with the rising burden of obesity, chronic cardiac and renal disease; all conditions overrepresented in the Southeastern U.S. - particularly in African Americans. Through a novel emergency department led intervention we aim to improve the care patients with gout receive, both during acute exacerbations and long-term. A secondary goal of the project is to concurrently enhance participation of minorities in biomedical research in the Deep South.
The 2 groups in the trial
- InterventionTreatment being tested
Storytelling A health literacy-appropriate and culturally-adapted intervention delivered on a tablet computer containing "storytelling" to improve patient gout knowledge and approaches to prevent flares, destigmatize gout, and enhance readiness to adopt available long-term treatments for gout including medications, diet, and exercise, or ii) usual gout care (control state).
Treatment: Storytelling
- ControlNo study treatment, for comparison
Usual Care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Care for Gout in the Southeast Enhancing Gout Minority Patients Care and Participation in Gout Clinical Research
- Record updated
- 23 October 2026